Patent · US Expired

Modified vaccinia virus Ankara (MVA) mutant and use thereof

US7767209B2 · kind B2 · utility

6Cited by

0References

15Claims

0Family size

Assignee

GSF-Forshungszentrum für Umwelt und Gesundheit, GmbH · DE

Inventors

Caroline Staib · Munich, DE
Gerd Sutter · Munich, DE
Sigried Kiesling · Munich, DE
Volker Erfle · Munich, DE

Key dates

Filing date	Mar 14, 2006
Grant date	Aug 3, 2010
Priority date	—
Expiry date	Mar 14, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to a MVA mutant and its use in the immunotherapy and vaccination against numerous diseases, in particular in the prevention and therapy of cancer and infectious diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.